Navigation Links
Omthera Stockholders Approve Acquisition by AstraZeneca
Date:7/16/2013

PRINCETON, N.J., July 16, 2013 /PRNewswire/ -- The stockholders of Omthera Pharmaceuticals, Inc. (NASDAQ: OMTH) (the "Company") voted today at a special meeting of stockholders to adopt the previously announced merger agreement providing for the acquisition of the Company by an affiliate of AstraZeneca PLC.  The votes cast by the Company's stockholders in favor of the proposal to adopt the merger agreement represented approximately 88.3 percent of the Company's issued and outstanding common stock entitled to vote as of June 13, 2013, the record date for the special meeting.

(Logo: http://photos.prnewswire.com/prnh/20130528/NY21129LOGO-a)

The receipt of the approval of the Company's stockholders of the proposal to adopt the merger agreement satisfies one of the conditions to consummation of the proposed merger.  The consummation of the merger remains subject to certain other closing conditions set forth in the merger agreement.

About Omthera Pharmaceuticals, Inc.

Omthera Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development and commercialization of new therapies for dyslipidemia and the treatment of cardiovascular disease. Epanova™, currently the Company's sole product candidate, is a late-stage, novel, omega-3 free fatty acid composition that meaningfully reduces triglycerides, improves other key lipid parameters and is expected to increase patient convenience with 2-gram once-a-day dosing with or without meals. Epanova™ is a coated soft gelatin capsule containing a complex mixture of polyunsaturated free fatty acids derived from fish oils, including multiple long-chain omega-3 and omega-6 fatty acids, with EPA, DHA, and docosapentaenoic acid being the most abundant forms of omega-3 fatty acids.
'/>"/>

SOURCE Omthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omthera Announces Waiver of Lock-Up Restriction
2. Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders
3. Omthera Pharmaceuticals, Inc. Stockholders Seeking More Money, Information in Buyout Should Contact Deans & Lyons Law Firm
4. Omthera Pharmaceuticals Announces First Quarter 2013 Financial Results
5. Covington Advises Omthera Pharmaceuticals on Merger with AstraZeneca
6. Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
7. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
8. Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk
9. Omthera Pharmaceuticals Announces Invitation to Attend Presentation of the Complete Data Sets from its Phase 3 EVOLVE and ESPRIT Clinical Studies
10. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
11. Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... WASHINGTON , July 30, 2015  Today we bring you a special edition ... wanted to remind you about some of our Medicare resources and continue highlighting the ... Check out our latest infographics and videos ... ... ...
(Date:7/30/2015)... Calif., July 30, 2015  Amgen (NASDAQ: ... second quarter of 2015. Key results include: ... second quarter of 2014 to $5,370 million, with ... Enbrel ® (etanercept), Prolia ® (denosumab), ... and XGEVA ® (denosumab). Unfavorable changes in ...
(Date:7/30/2015)... , July 30, 2015 Tianyin Pharmaceutical Inc. ... company that specializes in the patented biopharmaceutical, modernized traditional ... (API), provided updates regarding the notice it received on ... "Exchange") indicating that the Company was below certain of ... Sections 134 and 1101 of the NYSE MKT Company ...
Breaking Medicine Technology:Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2
... Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced today ... of ANA598 in combination with pegylated interferon and ribavirin. ... the United States Food and Drug Administration (FDA) and ... is expected to commence within the next several weeks. ...
... BD (Becton, Dickinson and Company) (NYSE: BDX ), ... present at the 29th Annual J. P. Morgan Healthcare Conference on ... A live webcast of BD,s presentation can be accessed from the ... for replay through Monday, January 17, 2011.   ...
Cached Medicine Technology:Anadys Pharmaceuticals Initiates Phase IIb Study of ANA598 in HCV Patients 2Anadys Pharmaceuticals Initiates Phase IIb Study of ANA598 in HCV Patients 3Anadys Pharmaceuticals Initiates Phase IIb Study of ANA598 in HCV Patients 4
(Date:8/1/2015)... ... 2015 , ... The condition where veins are enlarged and gnarled is known ... and discomfort. Those who spend a lot of time on their feet and standing ... doing what it can to create awareness and provide a cure in observance of ...
(Date:8/1/2015)... , ... August 01, 2015 , ... Brig and Lita ... are announcing the unification of their Healthy Home mission with the HOPE Movement of ... years, the founders of both companies have agreed to join their missions of purpose ...
(Date:8/1/2015)... ... ... Lume Wellness creators Alex, Robert, and Sam have announced update 3.0.1 to ... , The app is designed to track various metrics of wellness, including physical activity, ... health and use this information for positive behavior modification. Lume Wellness keeps track of ...
(Date:8/1/2015)... ... ... March 19, 2015 Phil Valentine – the Executive Director of Connecticut Community for Addiction Recovery ... off Springer Mountain and heading north. Since that day, Phil has hiked over 1400 miles ... by friends and family. He visited CCAR and left an inspirational message to his ...
(Date:7/31/2015)... ... 31, 2015 , ... When the weather turned hot and warm-season turfgrasses, such ... sod called Leisure Time(TM) zoysia . It's nicknamed LTZ(TM) for short. Incidentally, both ... this new type of sod, Super-Sod is giving away red Adirondack chairs with the ...
Breaking Medicine News(10 mins):Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2
... ... helping to familiarize consumers with the company’s newly redesigned website by hosting an online ... ... March 15, 2010 -- Tampa Bay, Florida-based manufacturer and distributor of natural health ...
... 2010 , ... ... for Kids , ... ...
... has joined the Harrington HealthCare family as part of Harrington Physician Services. , ... , , ... ... Dr. Oh joins Harrington ...
... globe are focused on the issue 24/7. , ... , , ... ... Rotary is committed to helping achieve the UN Millennium Development Goal that calls for a 50 percent ...
... - The film "Avatar" isn,t the only 3-D blockbuster making ... week unveiled a new technique for growing 3-D cell cultures, ... save millions of dollars in drug-testing costs. The research is ... is easy enough for most labs to set up immediately. ...
... New studies suggest promising new ways to ease atrial ... data presented at a major cardiology meeting Monday brought ... abnormal heartbeat that afflicts more than 2 million Americans. ... of the heart can quiver or race irregularly, rather ...
Cached Medicine News:Health News:ReNew Life Online Scavenger Hunt to Award Grand Prize Trip to Florida, Lunch with Brenda Watson 2Health News:Only 17% of Children Trust Dad for Advice About Bullying 2Health News:Only 17% of Children Trust Dad for Advice About Bullying 3Health News:Only 17% of Children Trust Dad for Advice About Bullying 4Health News:Only 17% of Children Trust Dad for Advice About Bullying 5Health News:Dr. Young-Ho Oh Joins Harrington Physician Services; Orthopedic Surgeon Will Enhance Hospital's Surgery Capabilities 2Health News:Dr. Young-Ho Oh Joins Harrington Physician Services; Orthopedic Surgeon Will Enhance Hospital's Surgery Capabilities 3Health News:Rotary Clubs Always Pumped for World Water Day 2Health News:Rotary Clubs Always Pumped for World Water Day 3Health News:3-D cell culture: Making cells feel right at home 2Health News:3-D cell culture: Making cells feel right at home 3Health News:Freezing, Medicating Away a Dangerous Irregular Heart Rhythm 2Health News:Freezing, Medicating Away a Dangerous Irregular Heart Rhythm 3Health News:Freezing, Medicating Away a Dangerous Irregular Heart Rhythm 4
15mm Open Blades, 28mm Maximum Spread; Available in small(S) and large (L), in stainless steel....
9mm Gently Curved Jaws, without lock; in Titanium....
8mm angled shaft with tip at 90 degree angle wtih rounded tear drop point; Tip available in left, right and center; (Right-SQT-225 and Left -SQT-227) In Titanium....
2.0mm Rounded Tip, 12mm From Tip to Bend Gently Curved, 15mm Shaft; In Titanium...
Medicine Products: